Difference in BPA uptake between glioma stem-like cells and their cancerous cells

被引：8

作者：

Yoshida, Fumiyo ^{[1
]}

Kurita, Tadashi ^{[1
,2
]}

Endo, Keita ^{[1
,2
]}

Nakai, Kei ^{[1
,3
]}

Shirakawa, Makoto ^{[4
]}

Zaboronok, Alexander ^{[1
]}

Tsurubuchi, Takao ^{[1
]}

Ishikawa, Eiichi ^{[1
]}

Matsumura, Akira ^{[1
]}

机构：

[1] Univ Tsukuba, Fac Med, Dept Neurosurg, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan

[2] Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan

[3] Ibaraki Prefectural Univ Hlth Sci, 4669-2 Ami, Inashiki, Ibaraki 3000331, Japan

[4] Fukuyama Univ, Dept Pharmaceut Sci, 1 Sanzo,Gakuen Cho, Fukuyama, Hiroshima 7290292, Japan

来源：

APPLIED RADIATION AND ISOTOPES | 2020年 / 164卷 / 164期

基金：

日本学术振兴会;

关键词：

Boron neutron capture therapy; Glioma; Stem cell; Boronophenylalanine; BORONOPHENYLALANINE; COMPLEX;

D O I：

10.1016/j.apradiso.2020.109234

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

Tumor sphere-forming (TS) glioma stem cells and cancerous TS cells were analyzed in vivo and in vitro. The boron concentration in murine TS tumors was higher than normal tissue. The boron concentration at 24 h was 0.80 +/- 0.09 mu g/10(7) in the TS cells, and 1.08 +/- 0.08 mu g/10(7) in the cancerous cells. The LAT-1 amino-acid transporter positive rate was 35.4% in the TS cells and 100% in the cancerous cells. These results suggested the relation between LAT-1 expression and boronophenylalanine concentration in vitro.

引用

页数：5

共 11 条

[1] Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, Shideng
Wu, Qiulian
McLendon, Roger E.
Hao, Yueling
Shi, Qing
Hjelmeland, Anita B.
Dewhirst, Mark W.
Bigner, Darell D.
Rich, Jeremy N.
[J]. NATURE, 2006, 444 (7120) : 756 - 760
[2] Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications
Bernstock, Joshua D.
Mooney, James H.
Ilyas, Adeel
Chagoya, Gustavo
Estevez-Ordonez, Dagoberto
Ibrahim, Ahmed
Nakano, Ichiro
[J]. JOURNAL OF NEUROSURGERY, 2020, 133 (03) : 655 - 663
[3] Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells
Kondo, T
Raff, M
[J]. SCIENCE, 2000, 289 (5485) : 1754 - 1757
[4] Current Approaches and Challenges in the Molecular Therapeutic Targeting of Glioblastoma
Mooney, James
Bemstock, Joshua D.
Ilyas, Adeel
Ibrahim, Ahmed
Yamashita, Daisuke
Markert, James M.
Nakano, Lchiro
[J]. WORLD NEUROSURGERY, 2019, 129 : 90 - 100
[5] Integrated analysis identifies different metabolic signatures for tumor-initiating cells in a murine glioblastoma model
Saga, Isako
Shibao, Shunsuke
Okubo, Jun
Osuka, Satoru
Kobayashi, Yusuke
Yamada, Sachiko
Fujita, Satoshi
Urakami, Kenichi
Kusuhara, Masatoshi
Yoshida, Kazunari
Saya, Hideyuki
Sampetrean, Oltea
[J]. NEURO-ONCOLOGY, 2014, 16 (08) : 1048 - 1056
[6] Invasion Precedes Tumor Mass Formation in a Malignant Brain Tumor Model of Genetically Modified Neural Stem Cells
Sampetrean, Oltea
Saga, Isako
Nakanishi, Masaya
Sugihara, Eiji
Fukaya, Raita
Onishi, Nobuyuki
Osuka, Satoru
Akahata, Masaki
Kai, Kazuharu
Sugimoto, Hachiro
Hirao, Atsushi
Saya, Hideyuki
[J]. NEOPLASIA, 2011, 13 (09): : 784 - U28
[7] Cancer stem cells in nervous system tumors
Singh, SK
Clarke, ID
Hide, T
Dirks, PB
[J]. ONCOGENE, 2004, 23 (43) : 7267 - 7273
[8] Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy
Sun, Ting
Li, Yanyan
Huang, Yulun
Zhang, Zizhu
Yang, Weilian
Du, Ziwei
Zhou, Youxin
[J]. ONCOTARGET, 2016, 7 (28) : 43095 - 43108
[9] Selective uptake of boronophenylalanine by glioma stem/progenitor cells
Sun, Ting
Zhou, Youxin
Xie, Xueshun
Chen, Guilin
Li, Bin
Wei, Yongxin
Chen, Jinming
Huang, Qiang
Du, Ziwei
[J]. APPLIED RADIATION AND ISOTOPES, 2012, 70 (08) : 1512 - 1518
[10] YOSHINO K, 1989, STRAHLENTHER ONKOL, V165, P127

← 1 2 →